Lifetime History of Depression Predicts Increased Beta-Amyloid Accumulation in Patients with Mild Cognitive Impairment

2015 ◽  
Vol 23 (3) ◽  
pp. S147-S150 ◽  
Author(s):  
Jun Ku Chung ◽  
Eric Plitman ◽  
Shinichiro Nakajima ◽  
Tiffany W. Chow ◽  
Mallar Chakravarty ◽  
...  
2019 ◽  
Vol 69 (2) ◽  
pp. 413-421 ◽  
Author(s):  
Kimberley Yuen ◽  
Neda Rashidi-Ranjbar ◽  
Nicolaas Paul L.G. Verhoeff ◽  
Sanjeev Kumar ◽  
Damien Gallagher ◽  
...  

2015 ◽  
Vol 49 (4) ◽  
pp. 1189-1190 ◽  
Author(s):  
Jun Ku Chung ◽  
Eric Plitman ◽  
Shinichiro Nakajima ◽  
Tiffany W. Chow ◽  
M. Mallar Chakravarty ◽  
...  

2015 ◽  
Vol 45 (3) ◽  
pp. 907-919 ◽  
Author(s):  
Jun Ku Chung ◽  
Eric Plitman ◽  
Shinichiro Nakajima ◽  
Tiffany W. Chow ◽  
M. Mallar Chakravarty ◽  
...  

2021 ◽  
pp. 1-7
Author(s):  
Wael K. Karameh ◽  
Ines Kortebi ◽  
Sanjeev Kumar ◽  
Damien Gallagher ◽  
Angela Golas ◽  
...  

ABSTRACT Objectives: To compare the prevalence of select cardiovascular risk factors (CVRFs) in patients with mild cognitive impairment (MCI) versus lifetime history of major depression disorder (MDD) and a normal comparison group using baseline data from the Prevention of Alzheimer’s Dementia with Cognitive Remediation plus Transcranial Direct Current Stimulation (PACt-MD) study. Design: Baseline data from a multi-centered intervention study of older adults with MCI, history of MDD, or combined MCI and history of MDD (PACt-MD) were analyzed. Setting: Community-based multi-centered study based in Toronto across 5 academic sites. Participants: Older adults with MCI, history of MDD, or combined MCI and history of MDD and healthy controls. Measurements: We examined the baseline distribution of smoking, hypertension and diabetes in three groups of participants aged 60+ years in the PACt-MD cohort study: MCI (n = 278), MDD (n = 95), and healthy older controls (n = 81). Generalized linear models were fitted to study the effect of CVRFs on MCI and MDD as well as neuropsychological composite scores. Results: A higher odds of hypertension among the MCI cohort compared to healthy controls (p < .05) was noted in unadjusted analysis. Statistical significance level was lost on adjusting for age, sex and education (p > .05). A history of hypertension was associated with lower performance in composite executive function (p < .05) and overall composite neuropsychological test score (p < .05) among a pooled cohort with MCI or MDD. Conclusions: This study reinforces the importance of treating modifiable CVRFs, specifically hypertension, as a means of mitigating cognitive decline in patients with at-risk cognitive conditions.


2014 ◽  
Vol 43 (1) ◽  
pp. 143-152 ◽  
Author(s):  
Byoung Seok Ye ◽  
Juhee Chin ◽  
Seong Yoon Kim ◽  
Jung-Sun Lee ◽  
Eun-Joo Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document